BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 19237840)

  • 1. [Influence of long-term gastric acid suppression therapy on the expression of serum gastrin, chromogranin A, and ghrelin].
    Chang YW
    Korean J Gastroenterol; 2009 Feb; 53(2):126-8. PubMed ID: 19237840
    [No Abstract]   [Full Text] [Related]  

  • 2. [Influence of long-term gastric acid suppression therapy on the expression of serum gastrin, chromogranin A, and ghrelin].
    Kim BW; Lee BI; Kim HK; Cho YS; Chae HS; Lee HK; Kim HJ; Han SW
    Korean J Gastroenterol; 2009 Feb; 53(2):84-9. PubMed ID: 19237833
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gastric exocrine and endocrine cell morphology under prolonged acid inhibition therapy: results of a 5-year follow-up in the LOTUS trial.
    Fiocca R; Mastracci L; Attwood SE; Ell C; Galmiche JP; Hatlebakk J; Bärthel A; Långström G; Lind T; Lundell L;
    Aliment Pharmacol Ther; 2012 Nov; 36(10):959-71. PubMed ID: 22998687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gastroduodenal Ulceration in Small Animals: Part 2. Proton Pump Inhibitors and Histamine-2 Receptor Antagonists.
    Daure E; Ross L; Webster CR
    J Am Anim Hosp Assoc; 2017; 53(1):11-23. PubMed ID: 27841679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination therapy.
    Katz P
    Postgrad Med; 2000 May; 107(5 Suppl):31-3; discussion 33-4. PubMed ID: 19667512
    [No Abstract]   [Full Text] [Related]  

  • 6. Gastric acid suppressants--too much of a good thing?
    Logan IC; Sumukadas D; Witham MD
    Age Ageing; 2010 Jul; 39(4):410-1. PubMed ID: 20507846
    [No Abstract]   [Full Text] [Related]  

  • 7. Rebound hypersecretion after inhibition of gastric acid secretion.
    Qvigstad G; Waldum H
    Basic Clin Pharmacol Toxicol; 2004 May; 94(5):202-8. PubMed ID: 15125689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term acid control and proton pump inhibitors: interactions and safety issues in perspective.
    Freston JW
    Am J Gastroenterol; 1997 Apr; 92(4 Suppl):51S-55S; discussion 55S-57S. PubMed ID: 9127627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Bleeding and pneumonia in intensive care unit patients given proton pump inhibitor or histamine-2 receptor antagonist for prevention of stress ulcer: a Meta analysis].
    Zhou JF; Wan XY; Huang W; Han LL
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2010 Apr; 22(4):221-5. PubMed ID: 20398466
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical use of proton-pump inhibitors but not H2-blockers or antacid/alginates raises the serum levels of amidated gastrin-17, pepsinogen I and pepsinogen II in a random adult population.
    Agréus L; Storskrubb T; Aro P; Ronkainen J; Talley NJ; Sipponen P
    Scand J Gastroenterol; 2009; 44(5):564-70. PubMed ID: 19263272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Antisecretory therapy strategy for patients with bleeding and perforated gastroduodenal ulcers].
    Evseev MA; Ivakhov GB; Golovin RA
    Khirurgiia (Mosk); 2009; (3):46-52. PubMed ID: 19391208
    [No Abstract]   [Full Text] [Related]  

  • 12. Randomised trial of the effect of a gastrin/CCK
    Boyce M; van den Berg F; Mitchell T; Darwin K; Warrington S
    Eur J Clin Pharmacol; 2017 Feb; 73(2):129-139. PubMed ID: 27796466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Serum concentration of prolactin, gastrin and glycocholic acid in patient with peptic ulcer treated with ranitidine].
    Przybyłowski J; Kowalski D; Widłak H; Kowalska K; Maślany P
    Pol Tyg Lek; 1995; 50(1-35):794-6. PubMed ID: 11785198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Gastric acid secretion inhibitors: H2 receptor antagonists (H2RA), proton pump inhibitors (PPI) or acid pump antagonists (APA)].
    Mazure PA
    Acta Gastroenterol Latinoam; 1996; 26(4):263-5. PubMed ID: 9335935
    [No Abstract]   [Full Text] [Related]  

  • 15. [Adjuvant treatment of peptic ulcer bleeding].
    Schilling D; Hartmann D; Eickhoff A; Jakobs R; Riemann JF
    Dtsch Med Wochenschr; 2005 Feb; 130(7):344-8. PubMed ID: 15712023
    [No Abstract]   [Full Text] [Related]  

  • 16. Normal and proton pump inhibitor-mediated gastrin levels in infants 1 to 11 months old.
    Treem W; Hu P; Sloan S
    J Pediatr Gastroenterol Nutr; 2013 Oct; 57(4):520-6. PubMed ID: 23689261
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Control of gastric acid secretion in health and disease.
    Schubert ML; Peura DA
    Gastroenterology; 2008 Jun; 134(7):1842-60. PubMed ID: 18474247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of proton-pump inhibitor therapy on serum chromogranin a level.
    Pregun I; Herszényi L; Juhász M; Miheller P; Hritz I; Patócs A; Rácz K; Tulassay Z
    Digestion; 2011; 84(1):22-8. PubMed ID: 21304238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of three H2-receptor antagonists (cimetidine, famotidine, ranitidine) on serum gastrin level.
    Ohsawa T; Hirata W; Higichi S
    Int J Clin Pharmacol Res; 2002; 22(2):29-35. PubMed ID: 12503773
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acid suppression and pneumonia: a clinical indication for rational prescribing.
    Gregor JC
    JAMA; 2004 Oct; 292(16):2012-3. PubMed ID: 15507589
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.